C4 Therapeutics Inc.

NASDAQ: CCCC · Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.46
0.20%
After-hours: Aug 15, 2025, 06:51 PM EDT

C4 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-105.32M -132.49M -128.18M -83.89M
Depreciation & Amortization
1.82M 1.88M 1.68M 1.49M
Stock-Based Compensation
29.66M 27.23M 30.02M 21.51M
Other Working Capital
-930K 3.12M -17.69M -25.05M
Other Non-Cash Items
1.03M 3.48M 7.32M 2.13M
Deferred Income Tax
n/a n/a n/a 1.88M
Change in Working Capital
7.65M -6.94M -16.78M -30.09M
Operating Cash Flow
-65.16M -106.84M -105.94M -86.97M
Capital Expenditures
-180K -1.71M -5.5M -1.28M
Cash Acquisitions
n/a n/a -63.92M 188.06M
Purchase of Investments
-284.32M -129.9M -219.53M -537.74M
Sales Maturities Of Investments
233.23M 289.95M 283.44M 349.68M
Other Investing Acitivies
n/a n/a 63.92M -188.06M
Investing Cash Flow
-51.27M 158.35M 58.42M -189.34M
Debt Repayment
n/a -12.5M n/a n/a
Common Stock Repurchased
-194K -110K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.16M 426K 1.15M 1.94M
Financial Cash Flow
45.34M 45.49M 1.15M 171.4M
Net Cash Flow
-71.09M 97M -46.37M -104.9M
Free Cash Flow
-65.34M -108.55M -111.44M -88.24M